Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ORAI calcium release-activated calcium modulator 3 | Starlite/ChEMBL | References |
Homo sapiens | ORAI calcium release-activated calcium modulator 2 | Starlite/ChEMBL | References |
Homo sapiens | ORAI calcium release-activated calcium modulator 1 | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_130743 | All targets in OG5_130743 |
Schistosoma mansoni | Protein orai-1 | Get druggable targets OG5_130743 | All targets in OG5_130743 |
Schistosoma japonicum | IPR012446,Protein of unknown function DUF1650,domain-containing | Get druggable targets OG5_130743 | All targets in OG5_130743 |
Echinococcus multilocularis | calcium release activated calcium channel | Get druggable targets OG5_130743 | All targets in OG5_130743 |
Schistosoma mansoni | Protein orai-1 | Get druggable targets OG5_130743 | All targets in OG5_130743 |
Echinococcus granulosus | calcium release activated calcium channel | Get druggable targets OG5_130743 | All targets in OG5_130743 |
Brugia malayi | hypothetical protein | Get druggable targets OG5_130743 | All targets in OG5_130743 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.1323 | 0.5 | 0.5 |
Echinococcus multilocularis | calcium release activated calcium channel | 0.1323 | 0.5 | 0.5 |
Echinococcus granulosus | calcium release activated calcium channel | 0.1323 | 0.5 | 0.5 |
Schistosoma mansoni | Protein orai-1 | 0.1323 | 0.5 | 0.5 |
Schistosoma mansoni | Protein orai-1 | 0.1323 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 11.8 uM | Inhibition of ORAl1/2/3 in HEK293 cells assessed as inhibition of Cd2+ influx after 10 mins by FLIPR assay in presence of thapsigargin | ChEMBL. | 23602525 |
IC50 (binding) | = 13.2 uM | Inhibition of ORAl1/2/3 in HEK293 cells assessed as inhibition of Ca2+ influx after 10 mins by FLIPR assay in presence of thapsigargin | ChEMBL. | 23602525 |
IC50 (binding) | > 500 uM | Inhibition of human TRPV6 transfected in HEK293 cells assessed as inhibition of Cd2+ influx after 5 mins by FLIPR assay | ChEMBL. | 23602525 |
IC50 (binding) | > 500 uM | Inhibition of human TRPV6 transfected in HEK293 cells assessed as inhibition of Ca2+ influx after 5 mins by FLIPR assay | ChEMBL. | 23602525 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.